4T1 tumor-bearing mice were randomly grouped and treated with PBS, siRNA2@HPVP plus IgG, siRNA2@HPVP plus anti-IFNAR1 antibody, and siRNA2@HPVP, respectively. Here, IFNAR1 is linked to neoplasm.